Results 61 to 70 of about 809,888 (290)

Dramatic Tumor Shrinkage of Locally Advanced and Inoperable Adenoid Cystic Carcinoma after Intra-arterial Chemotherapy

Journal of Cancer Research and Practice, 2015
Adenoid cystic carcinoma is rare and usually arises in the salivary glands. It grows slowly, but is characterized by easy perineural invasion with local infiltration and distant metastasis.
Fu-Jen Hsueh, Huai-Cheng Huang, Ruey-Long Hong   +2 more
doaj   +1 more source

Detecting MYB and MYBL1 Fusion Genes in Tracheobronchial Adenoid Cystic Carcinoma by Targeted RNA-Sequencing

Modern Pathology, 2019
Primary tracheobronchial adenoid cystic carcinoma is rare, accounting for less than 1% of all lung tumors. Many adenoid cystic carcinomas have been reported to have a specific chromosome translocation t(6;9)/MYB-NFIB.
J. Pei, D. Flieder, A. Patchefsky, Jacqueline N. Talarchek, H. Cooper, J. Testa, Shuan-Zeng Wei   +6 more
semanticscholar   +1 more source

Bone‐Anchored Implant Survival in Oncologic Facial Prosthetic Rehabilitation

Head &Neck, EarlyView.
ABSTRACT Background Published survival rates for bone‐anchored craniofacial implants exceed 85%, but derive largely from mixed populations. Whether these apply to head and neck oncologic surgery remains uncertain. Methods Retrospective survival analysis of implants placed for prosthetic rehabilitation following extirpative surgery at a UK center (2005 ...
Oliver Blanshard, Sarah Jones, Peter M. Clarke, Jonathan M. Bernstein   +3 more
wiley   +1 more source

Fine needle aspiration cytology of basal cell adenoma of parotid simulating adenoid cystic carcinoma

Journal of Cytology, 2018
Basal cell adenoma is a rare type of monomorphic salivary adenoma most commonly involving the parotid gland. Cytology of basal cell adenoma closely mimics many other benign and malignant basaloid neoplasms.
Subrata Pal, Palash Kr Mondal, Abhishek Sharma, Mrinal Sikder   +3 more
doaj   +1 more source

Adenoid cystic carcinoma: A case of rare breast cancer

Radiology Case Reports, 2022
Adenoid cystic carcinoma is a rare form of breast cancer accounting for 0.1%-1.0% of all mammary malignancies. It is characterized by an indolent clinical course and favorable prognosis, contrary to other breast cancers.
Claudia Gordillo, DO, Anjeza Chukus, MD
doaj   +1 more source

Carcinoma adenoide cístico / Adenoid cystic carcinoma

Brazilian Journal of Development, 2022
O carcinoma adenoide cístico (CAC) é a neoplasia maligna mais frequente das glândulas salivares menores, caracteriza-se clinicamente por ser de crescimento lento, a localização mais frequente é o palato duro. Objetivo: O objetivo do presente trabalho será discorrer sobre as principais características do CAC.
Raiane Ferreira de Paula, Luciana Estevam Simonato, Karina Gonzalez Camara Fernandes   +2 more
openaire   +1 more source

Characterization of Perineural Invasion Parameters for Risk Stratification in Oral Squamous Cell Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background Perineural invasion (PNI) is an established adverse prognostic factor in oral squamous cell carcinoma (OSCC), but the implications of its extent as well as its relationship with surgical margin status and the extent of microscopic tumor spread remain unclear.
Michael A. Müller, Muriel D. Brada, Niels J. Rupp, Cosima E. Riemenschnitter, Simon Müller, Alexander M. Huber, Panagiotis Balermpas, Grégoire B. Morand   +7 more
wiley   +1 more source

Mithramycin inhibits epithelial-to-mesenchymal transition and invasion by downregulating SP1 and SNAI1 in salivary adenoid cystic carcinoma

Tumor Biology, 2017
Mithramycin exhibits certain anticancer effects in glioma, metastatic cerebral carcinoma, malignant lymphoma, chorionic carcinoma and breast cancer. However, its effects on salivary adenoid cystic carcinoma remain unclear.
Jiasu Li, Hongmei Gao, Lingxu Meng, Lin Yin   +3 more
doaj   +1 more source

Tolerability of Adjuvant Nivolumab in Esophageal or Gastroesophageal Junction Cancer: A Real‐World Study

International Journal of Cancer, EarlyView.
ABSTRACT Adjuvant nivolumab is approved for esophageal or gastroesophageal junction cancer after neoadjuvant chemoradiotherapy and resection. In the CheckMate‐577 trial, Grade 3–5 nivolumab‐related adverse events (AEs) occurred in 5% of patients, with early discontinuation due to toxicity in 9%. However, real‐world data on immunotherapy‐related adverse
Michelle Koops van ’t Jagt, Anniek Strijdhorst, Tamara Jessica Huizer, Esther Albertien Kleibeuker, Sarah Derks, Bianca Mostert, Hanneke van Laarhoven, Jacco Juri de Haan   +7 more
wiley   +1 more source

Optimizing surgical approaches for lacrimal gland adenoid cystic carcinoma to minimize cross-organ invasion [PDF]

International Journal of Ophthalmology
AIM: To evaluate the outcomes of eye-sparing surgery for lacrimal gland adenoid cystic carcinoma and the impact on tumor recurrence and orbital integrity.
Ming-Shen Ma, Ting-Ting Ren, Fu-Xiao Luan, Jing Li, Nan Wang, Yong Tao, Jian-Min Ma   +6 more
doaj   +1 more source